| 26.2.18
|
CVA Reading 1, p.34, pl. 21, n.20; Villing et al 2013-2015 (ORC) GG.174
|
|
| 26.2.20
|
CVA Reading 1, p.34, pl. 21, n.22; Villing et al 2013-2015 (ORC) GG.283;
|
|
| 26.2.21
|
CVA Reading 1, p.34, pl. 21, no.23; Villing et al 2013-2015 (ORC) GG.505
|
|
| 26.2.23
|
CVA Reading 1, p.34, pl. 21, no.25; Villing et al 2013-2015 (ORC) GD.0245 phase 2;
|
|
| 26.2.24
|
Fragment A
CVA Reading 1, p.34, pl. 21., no.26, 26; Villing et al 2013-2015 (ORC) GB.050 Phase 1 ;
Fragment B:
CVA Reading 1 p. 34, pl. XXI, no. 26 bis; Villing et al 2013-2015 GB. 049 Phase 1.
|
|
| 26.2.29
|
CVA Reading 1, p.34, pl. 21., no.31a-b; Villing et al 2013-2015 (ORC) GO.563;
|
|